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Introduction
Since its advent in the 1950s, percutaneous renal access
has evolved to be the preferred method for treating
many urologic conditions.1 Among techniques using
percutaneous renal access, percutaneous nephrostomy
(PCN) management of renal stones has been a
well-accepted procedure since the 1970s. Various
modifications have been made to the PCN technique
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Background: Percutaneous nephrostomy is almost a daily routine procedure in clinical urologic practice. Tract bleeding
and urine leakage along the percutaneous tract is a common event and bothersome to both patients and the surgeon.
Herein we introduce a simple technique of gelatin packing for stopping subsequent bleeding and urine leakage
immediately after a percutaneous nephrostomy lithotripsy (PCNL) procedure.
Methods: PCNL, using a tubeless technique, was performed in 15 patients with renal calculi. In all cases, stones were
removed using grasping forceps after the stones were disintegrated with a lithoclast. In all patients, a retrograde internal
ureteral stent was put in place before the PCNL procedure, as was a Foley catheter for bladder drainage. A gelatin patch
sealant was placed in the nephrostomy cortical tract under nephroscopic vision, immediately after the PCNL procedure.
Another 15 patients, treated using a standard PCNL with tube drainage post-PCNL, were enrolled as a control group.
Results: The stone burden, mean operative time, and stone-free rate (67% versus 73%, p = 0.33) were not statistically
different between the 2 groups. In the 15 patients who received tubeless PCNL treatment, there were no severe
complications related to the gelatin packing in the nephrostomy tract, and no significant bleeding or urine leakage
occurred after the packing. The necessity for blood transfusion was much lower in the tubeless group as compared
with the tube-drainage group (6.6% versus 26.7%; 0.2 ( 0.1 units versus 0.9 ( 0.5 units, p = 0.013). Tubeless
patients began ambulation and were discharged from the hospital earlier (3.4 days versus 5.1 days, p = 0.035)
than those in the tube-drainage group. Analgesic requirement was significantly less with the gelatin sealant technique
when compared with the tube drainage group (85 ( 20 mg versus 185 ( 25 mg, p = 0.008).
Conclusion: Gelatin sealant packing is an alternative, available, and feasible method for preventing bleeding and urine
leakage postoperatively in selected patients receiving tubeless PCNL. [J Chin Med Assoc 2006;69(4):162–165]
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and equipment in an attempt to decrease the morbidity
of the procedure and increase cost-effectiveness,
including the tubeless method.2 Nevertheless, urine
leakage and bleeding along the nephrostomy tract
after the PCN procedure is still a main concern. Herein
is described a gelatin patch sealant method that is
designed to achieve hemostasis and hydrostasis after
PCN procedures. The results of standard tube drainage
and sealant groups are compared.
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Methods
Patient enrollment
Percutaneous nephrostomy lithotripsy (PCNL), using
the modified tubeless technique, was performed
nonselectively in 11 men and 4 women. Another 15
patients who received traditional PCNL were identified
as the control group in this study. The indications for
PCNL included a renal stone burden of 2.5 cm or
greater in length, or an association with obstruction.
The stone burden was calculated from the measurements
of the sum of the area of each stone in cm2.
Modified technique using gelatin
sealant packing
In all cases, stones were removed using a direct approach
with lithoclast. In our hospital, the PCN catheter
usually was inserted by a senior radiologist the day
before the PCNL procedure in order to lessen bleeding.
On the table, 1 access tract was created, using internal
urethrotome on each renal unit along the PCN catheter
guide under nephroscopic direct vision with the
conjunction passage of a 30–32F working sheath
(Figure 1A). After completion of the stone extraction
using lithoclast, the nephrostomy tract was packed
with a patch of absorbable gelatin sponge (Gelfoam,
Pharmacia & Upjohn, Kalamazoo, MI, USA) in
proper size (Figure 1B). Then the working sheath
was removed, and a drainage tube was left in the
retroperitoneal space for 12–24 hours. Patients who
were hemodynamically stable, and whose pain was
controllable with oral narcotic medications, were
discharged the day after PCNL with the retroperitoneal
tube having been removed.
Postoperative follow-up and statistical analysis
The medical records of the patients were reviewed
with respect to stone burden, operative time, stone-
free outcome, length of hospitalization, analgesic
requirement, transfusion rate, and complications.
Residual stones were not recognized as a complication
after PCNL. Another 15 cases of patients treated
with PCNL and temporary nephrostomy tube
drainage (1–3 days) were enrolled as comparison in
the same period. All parameters were analyzed
statistically using Mann-Whitney rank sum and Chi-
square tests. A p value of 0.05 or less was considered
significant.
Results
The average age of the patients was 55.6 years (range
43–67 years) in the standard tube drainage group
and 54.5 years (range 41–65 years) in the gelatin
sealant group. There was no significant difference
in gender and stone site distribution (Table 1). The
stone burden was not significantly different between
the groups (5.3 ( 2.2 cm2 versus 4.5 ( 1.6 cm2, p =
0.36); neither was the mean operative time (67 ( 21
minutes versus 52 ( 16 minutes, p = 0.20). The blood
transfusion rate was much lower in the gelatin sealant
group when compared with the tube-drainage group
(6.6% versus 26.7%, p = 0.0001; 0.2 ( 0.1 units versus
0.9 ( 0.5 units, p = 0.013).
The stone-free rate immediately after PCNL was
similar in both groups (67% versus 73%, p = 0.33).
Residual stones were all treated with extracorporeal
shock wave lithotripsy at the outpatient clinic.
Figure 1. (A) The procedure of percutaneous nephrostomy lithotripsy. (B) Modified tubeless percutaneous nephrostomy lithotripsy with
gelatin sealant packing in the parenchymal tract.
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The analgesic requirement was significantly less for
those patients receiving the gelatin-sealant technique
when compared with the tube-drainage group (85 (
20 mg versus 185 ( 25 mg, p = 0.008). The average
length of hospitalization was significantly less in the
sealant-tubeless group (3.4 days, p = 0.035) compared
with the tube-drainage group (5.1 days). No severe
complications or morbidities occurred in either group.
Discussion
In 1976, Fernstrom and Johansson1 first introduced
removal of a renal calculus via a percutaneous tract.
Since then, PCNL has undergone numerous
refinements in both instrumentation and technique,
including tubeless PCNL and mini-PCNL.2–4 These
modifications were introduced to achieve a reduction
in postoperative analgesia requirement, hospital
stay and cost, as well as to decrease trauma to the
percutaneous tract (Table 2).2–7 In 1997, Bellman et
al2 challenged the requirement for routine placement
of a nephrostomy tube after percutaneous renal
surgery, introducing the so-called tubeless method.
Their recommendations for the use of tubeless PCNL
include a small stone burden of less than 3 cm in
diameter, only 1 access, no distal obstruction, no
significant bleeding or collecting system perforation
during the primary PCNL, and no requirement of
secondary PCNL.8 Nevertheless, low or even less
morbidity is a major concern when performing tubeless
PCNL in comparison with standard PCNL. Among
the possible complications, renal bleeding and urinary
leakage are common.
Table 2. Comparison of PCNL outcomes in different reports
Year
Author and PCNL No. of Stone Blood Stone-free Hospitalization,
Complications
reference no. method cases burden, cm2 transfusion, % rate, % d
1997 Bellman et al2 Tubeless 50 – – – 0.6 0
1999 Goh and Wolf5 Standard 13 3.0 7.6 92 3.6 3 (perforation, leak)
Tubeless 8 1.8 0 75 2.3 1 (ureteral obstruction)
2000 Monga and Oglevie3 Mini-PCN 21 2.8 0 90 1.1 1 (atelectasis)
2001 Feng et al7 Standard 10 8.4 10 38 4.1 1 (bleeding)
Mini-PCN 9 4.9 11 63 3.2 1 (bleeding)
Tubeless 8 4.4 0 71 1.9 0
2002 Limb and Bellman6 Tubeless 86 3.3 6 93 1.3 1 (pseudoaneurysm)
2005 Current series Standard 15 5.3 26.7 67 5.1 0
Tubeless 15 4.5 6.6 73 3.4 0
with sealant
PCNL = percutaneous nephrostomy lithotripsy; PCN = percutaneous nephrostomy.
Table 1. Demographics and treatment outcomes in patients who received standard or modified tubeless percutaneous
nephrostomy lithotripsy
Parameters
Tube-drainage group Gelatin-sealant group
p value
(n = 15) (n = 15)
Age, yr 55.6 ( 9.5 54.5 ( 12.4 0.78
Sex, M:F 11:4 9:6 0.80
Stone site, Lt:Rt 8:7 7:8 0.45
Stone burden, cm2 5.3 ( 2.2 4.5 ( 1.6 0.21
Operative time, min 67 ( 21 52 ( 16 0.20
Blood transfusion
cases, n (%) 4 (26.7) 1 (6.6) 0.0001
units 0.9 ( 0.5 0.2 ( 0.1 0.013
Stone-free rate, n (%) 10 (67) 11 (73) 0.33
Demerol analgesics, mg 185 ( 25 85 ( 20 0.008
Length of stay, d (range) 5.1 ( 2.5 (3–10) 3.4 ( 1.6 (3–5) 0.035
Complications 0 0
Mean ( SD
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Diabetes, multiple-tract procedures, prolonged
operative time, and the occurrence of intraoperative
complications are associated with significantly increased
blood loss during PCNL. Maneuvers that may reduce
blood loss and transfusion rate include ultrasound-
guided access, use of Amplatz or balloon dilatation
systems, reduction in the operative time, and staging
the procedure in cases of a large stone burden or
intraoperative complications.9 Bleeding following
PCNL can arise from a variety of sources and may
occur from the mucosa of the collecting system, renal
parenchyma, an arteriovenous fistula or pseudoaneurysm,
or the intercostals or subcutaneous vessels.2 Bellman
et al2 suggested a Kay tamponade balloon for direct
pressure to limit intract hemorrhage.
In addition to tamponade balloon, Jou et al10 have
proposed cauterization along the PCNL tract to
decrease the possibility of postoperative bleeding in
selected patients.
Lee et al11 have described the use of a commercial
gelatin matrix hemostatic sealant as an adjunct to
tubeless percutaneous nephrolithotomy to help
preclude bleeding complications, and, from their
pilot experience, they concluded that it provided
immediate and effective hemostasis. However,
although commercial gelatin matrix hemostatic
sealant is effective, it is expensive. The gelatin sponge
can be absorbed within 2 weeks and be replaced by
parenchymal tissue. In our preliminary experience of
limited cases, this modified technique could achieve
both aims, reducing bleeding and leakage after PCNL.
The longer hospital stay in our series was because of
the 2-stage PCNL procedure with PCN tube insertion
on the first day, followed by PCNL the next day, in an
attempt to lessen hemorrhage during PCNL.
In conclusion, when performing tubeless PCNL in
selected cases with renal stone disease, gelatin sponge
sealant is an alternative, applicable, and feasible material
for hemostatic and leakage prevention.
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